NasdaqCM - Nasdaq Real Time Price USD
MoonLake Immunotherapeutics (MLTX)
37.62
-0.04
(-0.11%)
At close: May 16 at 4:00:00 PM EDT
37.62
0.00
(0.00%)
After hours: May 16 at 4:05:08 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 5 | 8 |
| Avg. Estimate | -0.77 | -0.78 | -2.98 | -3.54 |
| Low Estimate | -0.83 | -0.83 | -3.14 | -4.07 |
| High Estimate | -0.71 | -0.72 | -2.8 | -1.83 |
| Year Ago EPS | -0.39 | -0.56 | -1.89 | -2.98 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 14 | 14 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.28 | -0.45 | -0.59 | -0.74 |
| EPS Actual | -0.39 | -0.56 | -0.72 | -0.63 |
| Difference | -0.11 | -0.11 | -0.13 | 0.11 |
| Surprise % | -37.71% | -23.33% | -21.46% | 14.34% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.77 | -0.78 | -2.98 | -3.54 |
| 7 Days Ago | -0.78 | -0.77 | -3.06 | -3.66 |
| 30 Days Ago | -0.78 | -0.77 | -3.09 | -3.67 |
| 60 Days Ago | -0.8 | -0.78 | -3.14 | -3.61 |
| 90 Days Ago | -0.69 | -0.73 | -2.53 | -3.3 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | 2 | 1 | -- | -- |
| Down Last 30 Days | 2 | 1 | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MLTX | -98.67% | -39.05% | -57.46% | -18.85% |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 5/13/2025 |
| Reiterates | Needham: Buy to Buy | 4/30/2025 |
| Initiated | RBC Capital: Outperform | 3/18/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/27/2025 |
| Maintains | Needham: Buy to Buy | 2/27/2025 |
Related Tickers
PTGX Protagonist Therapeutics, Inc.
44.49
+0.18%
RVMD Revolution Medicines, Inc.
39.54
+0.25%
SRRK Scholar Rock Holding Corporation
30.55
-0.91%
APGE Apogee Therapeutics, Inc.
40.62
-0.05%
KYMR Kymera Therapeutics, Inc.
30.25
+0.77%
AKRO Akero Therapeutics, Inc.
38.87
-2.73%
MRUS Merus N.V.
41.56
+3.69%
VRDN Viridian Therapeutics, Inc.
12.94
+2.54%
VERA Vera Therapeutics, Inc.
21.25
-0.38%
ASND Ascendis Pharma A/S
157.60
+0.04%